Cooper Companies | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 14.16B 745M 2024-12
Align Technology USD 2.04B 25.59M 2024-12
AtriCure USD 73.42M 1.01M 2024-12
Avanos Medical USD 165.9M 47M 2024-12
Bausch Health Companies USD 4.51B 137M 2024-09
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dentsply International USD 1.59B 47M 2024-12
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Haemonetics USD 253.23M 20.71M 2024-12
Hologic USD 1B 34.8M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
J&J USD 50.32B 1.44B 2024-12
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 216.4M 15.32M 2024-12
Novartis USD 28.69B 560M 2024-12
ResMed USD 851.96M 52.12M 2024-12
STAAR Surgical USD 70.31M 3.96M 2024-12
Steris USD 891.12M 85.64M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Cooper Companies Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.